Haemophilia Centre certification system across Europe: The Belgian experience

Hermans, Cédric
(2014) Blood Transfusion — Vol. 12, n° Suppl/ 3, p. S497-S500 (2014)

Files

061-14_s497-5001.pdf
  • Restricted Access
  • Adobe PDF
  • 698.65 KB
Request a copy

Details

Authors
Abstract
Haemophilia is characterised by recurrent bleeding, especially into the joints, which eventually results in chronic crippling arthropathy. Since the early 1960s, replacement therapy using intravenous clotting factors has become available1. Clotting factor concentrates can be administered as on-demand therapy in the event of bleeding episodes, or at regular time intervals, often three times a week, as prophylaxis-therapy to prevent bleeding. (...)
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hermans, C. (2014). Haemophilia Centre certification system across Europe: The Belgian experience. Blood Transfusion, 12(Suppl/ 3), S497-S500. https://doi.org/10.2450/2014.0061-14s (Original work published 2014)